Back to funds

Exome Asset Management LLC

Updated 6 days ago

Managed by Exome Asset Management Llc • Latest filing Q3 2026

Portfolio value
$153M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$209.1M
Q1 2026$193.3M
Q2 2026$162.1M
Q3 2026$153M

Top holdings

55 positions as of Q3 2026

View filing
G

GUARDANT HEALTH INC

Value
$12M
Shares
67.5K
% Port
7.87%
T

TG THERAPEUTICS INC

Value
$10.5M
Shares
187.7K
% Port
6.84%
A

ABIVAX SA

Value
$9M
Shares
90.9K
% Port
5.88%
P

PRAXIS PRECISION MEDICINES I

Value
$8.6M
Shares
29.7K
% Port
5.65%
C

COGENT BIOSCIENCES INC

Value
$6.7M
Shares
210.5K
% Port
4.41%
L

ELI LILLY & CO

Value
$6.4M
Shares
5.5K
% Port
4.15%
N

NATERA INC

Value
$5.7M
Shares
13.8K
% Port
3.73%
V

VERA THERAPEUTICS INC

Value
$5.2M
Shares
159.6K
% Port
3.37%
V

VIKING THERAPEUTICS INC

Value
$4.8M
Shares
147.5K
% Port
3.14%
I

IONIS PHARMACEUTICALS INC

Value
$4.8M
Shares
107.0K
% Port
3.12%
E

ENLIVEN THERAPEUTICS INC

Value
$4.6M
Shares
100.2K
% Port
3.00%
C

CARIS LIFE SCIENCES INC

Value
$4.5M
Shares
146.1K
% Port
2.92%
N

NEKTAR THERAPEUTICS

Value
$4.5M
Shares
73.7K
% Port
2.92%
C

CYTOKINETICS INC

Value
$4M
Shares
60.1K
% Port
2.59%
V

VERASTEM INC

Value
$3.5M
Shares
429.0K
% Port
2.26%
M

MAZE THERAPEUTICS INC

Value
$3.1M
Shares
114.7K
% Port
2.04%
R

RHYTHM PHARMACEUTICALS INC

Value
$3.1M
Shares
32.2K
% Port
2.00%
T

10X GENOMICS INC

Value
$2.7M
Shares
30.1K
% Port
1.78%
A

ALKERMES PLC

Value
$2.5M
Shares
61.3K
% Port
1.62%
U

UNITED THERAPEUTICS CORP DEL

Value
$2.2M
Shares
4.1K
% Port
1.46%

Explore